Stock RVV REVIVE THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Revive Therapeutics Ltd Toronto S.E.

Equities

RVV

CA7615161030

Delayed Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Revive Therapeutics Ltd +6.67% -11.11%
Jul. 02 Revive Therapeutics Ltd. Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure CI
Jun. 12 Revive Therapeutics Ltd. Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long Covid CI
040c7.5J7tAuBWYsGtoGOY0Jvly5rJbM8FYiT_2mknFsCjtcc.3P_AQ7oFAY_m_yfRhK69k92nQZAxNkuJkxpBL4_u8ZWh6aFvsTgDl8TMJg~57a24253e6d94ad06eace6cabea864aa
  1. Stock Market
  2. Equities
  3. RVV Stock
  4. RVV Stock
  5. Charts Revive Therapeutics Ltd
  6. News Chart